This trip might just be worth taking.

New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive disorder.

That’s noteworthy, since traditional antidepressants can be slow to work, cause side effects and fail to help many patients.

Across the country, around 22.5 million American adults , roughly 8.8% of those 18 and older, have at least one major depressive episode each year.

The disorder causes persistent sadness and a loss of interest in almost every part of life, affecting how people think, feel and behave — and often making work, school and relationships a struggle.

In the hunt for more effective treatments, scientists have increasingly focused on psychedelic-assisted therapy in recent years, including with dr

See Full Page